title: Human pancreatic cancer growth is inhibited by peptide YY and BIM-43004-1.
abstract: Exogenous peptide YY (PYY) decreases pancreatic exocrine secretion, pancreatic endocrine function, and pancreatic blood flow. We hypothesized that pancreatic cancer cell growth may be inhibited by PYY and a new synthetic analog, BIM-43004-1. Two human pancreatic ductal adenocarcinomas, PANC-1 and Mia PaCa-2, were examined in tissue cultures. Viable pancreatic cancer cells were counted with trypan blue on a hemocytometer slide. Cells (10K, 20K, 40K, and 80K) were cultured and allowed to grow for 36 hr (n = 14/cell concentration). Pancreatic cancer cells received either PYY or BIM-43004-1 at various concentrations. Control tissue cultures received an equivalent volume of saline inoculation. After incubation with the above peptides for 24 hr, MTT tetrazolium bromide was added to assay mitochondrial activity of pancreatic cancer cells in response to PYY and its analog. MTT assay reveals a significant decrease in pancreatic cancer cell growth when PYY and BIM-43004-1 are added to the cell culture. Results in Mia PaCa-2 reveal a 24% cell growth reduction after exposure to PYY and a 23% reduction in cell growth when treated with BIM-43004-1. In PANC-1 cells, a 25% reduction in growth of cells is noted after PYY treatment and a 24% reduction in growth after BIM-43004-1 treatment. (means +/- SEM, P < 0.05 by Student's t test). Our results reveal a significant reduction in human ductal pancreatic cancer growth when treated with either PYY or its analog, BIM-43004-1. These agents may be useful hormonal adjuncts in the chemotherapy of pancreatic adenocarcinoma.
authors.affiliation: Department of Surgery, UCLA Medical Center, USA.
authors.forename: C D
authors.initials: CD
authors.lastname: Liu
authors.forename: A
authors.initials: A
authors.lastname: Balasubramaniam
authors.forename: R E
authors.initials: RE
authors.lastname: Saxton
authors.forename: M
authors.initials: M
authors.lastname: Paiva
authors.forename: D W
authors.initials: DW
authors.lastname: McFadden
mesh_terms: D000242:Cyclic AMP / Q000032:analysis; D006801:Humans; D010190:Pancreatic Neoplasms / Q000188:drug therapy* / Q000473:pathology; D010446:Peptide Fragments / Q000494:pharmacology; D019894:Peptide YY; D010455:Peptides / Q000494:pharmacology*; D014407:Tumor Cells, Cultured
chemical_list: C094215:BIM 43004-1; D010446:Peptide Fragments; D010455:Peptides; D019894:Peptide YY; D000242:Cyclic AMP